AGMB NASDAQ BE

AgomAb Therapeutics NV - ADRs representing one common share.

Website · IPO Feb 2026
$10.72
▼ $-1.06 (-9.00%)
Vol 185K

Wall Street Consensus

10 analysts · Apr 2026
4
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Quarterly Revenue & Earnings

Quarter 2024-1…
Revenue
Net Income -$11.7M

Financial Health

Free Cash Flow
-$12.8M
Net Debt
-$128.3M
Cash
$129.6M
Total Debt
$1.3M
As of Sep 30, 2025

Peer Comparison

Ticker Mkt Cap P/E P/S ROE Margin Beta
AGMB

Latest News

No related news yet